the Image

Clinical Trial Details

If you are a patient or a caregiver and would like to learn more our cancer clinical trials call toll-free 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials) or email cancerclinicaltrials@bsd.uchicago.edu .

Share this:
Brief Title Phase II Study of Intraperitoneal NanoPac® in Patients With Ovarian Cancer
Official Title Phase II Study of Four Dose Levels of Intraperitoneal NanoPac® Plus IV Carboplatin and Paclitaxel in Patients With Epithelial Ovarian Cancer Undergoing Cytoreductive Surgery
Principal Investigator Yamada, S. Diane
Brief Summary This study will evaluate NanoPac® administered intraperitoneally (IP) immediately post-cytoreductive surgery, followed by standard of care (SOC) intravenous (IV) chemotherapy, in women with ovarian cancer. The study will compare IP NanoPac® (plus IV chemotherapy) with SOC IV chemotherapy alone.
Gender Female
Ages 18 Years
Enrollment 61
Accepts Healthy Volunteers No
Lead Sponsor NanOlogy, LLCIndustry
Collaborator US Biotest, Inc.Industry
Study Design
Study Phase Phase 2
Study Type Interventional
Contact Name
Contact Phone 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials)
Condition Ovarian Carcinoma
Detail for Health Professional (on clinicaltrials.gov)
More clinical trials by this PI